BPC-157: What the Peptide Is and What the Evidence Actually Shows
Nearly everything sold about BPC-157 comes from rats and cells in a dish. No human trial has tested whether any of it happens in a person.
BPC-157 is a synthetic peptide, a lab-made chain of fifteen amino acids patterned on a fragment of a protein found in stomach fluid. It's stable in stomach acid, unusual for a peptide, which is the argument made for an oral form. It's sold online as capsules, an oral liquid, or an injectable powder, marketed for healing tendons, ligaments, muscle, and the gut. It has never been approved as a medicine in any country. It reaches buyers as a research chemical, a product with no check on its identity, dose, purity, or sterility.
In rats, BPC-157 speeds the healing of a surgically cut Achilles tendon, improves ligament and crushed-muscle recovery, closes gut fistulas, and promotes the growth of new blood vessels. Those animal results are consistent across a number of studies from a small group of labs, which is the reason for interest in the compound. No adequate human trial has tested whether BPC-157 is safe or effective in people for any of these uses. A result in an injured rat is a starting point for research; it does not show that the compound works in a person, and what a compound does in animals can differ from what it does in humans, in both direction and size.
This page describes the research. It does not recommend taking BPC-157, and gives no dose, here or anywhere on the site. The plainer routes to the healing people want from BPC-157 (graded loading, adequate protein, sleep, and progressive rehabilitation) have human trial evidence behind them and none of the unknowns of an unregulated injectable. Persistent tendon, joint, or gut symptoms deserve a diagnosis from a clinician or physical therapist. BPC-157 is banned in competitive sport, and the same blood-vessel growth proposed to help a wound heal raises an unanswered question about cancer risk that no long human study has looked at.